CANY
ASTH icon

Caxton Associates (New York)’s Astrana Health ASTH Stock Holding History

Caxton Associates (New York)’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,735
Closed -$201K – 746
2021
Q4 		$201K Buy
+2,735
New +$225K 0.02% 493

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Caxton Associates (New York)'s ASTH Position: Q1 2022 in Review

Caxton Associates (New York) sold out of Astrana Health (ASTH) in Q1 2022, closing a stake of 2,735 shares — an estimated $201K sold.

Caxton Associates (New York) first reported a position in ASTH in Q4 2021 and held it in 1 quarter. The position peaked at $201K in Q4 2021. 139 funds tracked by Wall St. Rank hold ASTH as of Q1 2022.

  • Caxton Associates (New York) reported no remaining Astrana Health position as of Q1 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 2,735 Astrana Health shares in Q1 2022, an estimated $201K.
  • Caxton Associates (New York) first reported a position in Astrana Health in Q4 2021 and held it in 1 quarter.
  • Caxton Associates (New York)'s Astrana Health position peaked at $201K in Q4 2021.
  • 139 funds tracked by Wall St. Rank held Astrana Health as of Q1 2022.

Based on Caxton Associates (New York)'s 13F filing for Q1 2022, filed 16 May 2022.